The Hidden Risks of Depo-Provera

Depo-Provera, a long-acting birth control injection, has been the subject of rising legal claims due to its potential link to brain tumors, specifically meningiomas. Manufactured by Pfizer, Depo-Provera has been widely used by women for contraception and to manage certain medical conditions. However, mounting evidence suggests that prolonged use of this contraceptive could lead to serious health risks, including the development of meningiomas, which has prompted lawsuits alleging insufficient warnings by the manufacturer.

What is Depo-Provera?

Depo-Provera is an injectable contraceptive used around the world for nearly 60 years. Depo-Provera was approved for use by the U.S. Food and Drug Administration (“FDA”) in 1992. Approximately one to two million women in the United States use Depo-Provera annually. Roughly 20% of all women in America have used Depo-Provera at some point in their lifetime. The dose used in the United States is 150 mg every 11-13 weeks, by injection into your muscle (arm or buttocks).

What is Depo-SubQ Provera 104?

Depo-SubQ is a lower dose progestin, which is used as a contraceptive and as treatment for endometriosis. Depo-SubQ is injected as a shot predominantly on your thigh or belly.

What is a Meningioma?

A meningioma is a brain or spinal tumor, predominantly slow growing and benign which compresses adjacent brain tissue and causes many issues, including but not limited to vision impairment, migraines, headaches, seizures, and numbness. Meningiomas account for 40% of primary tumors of the central nervous system. The incidence of meningioma in the United States is 9.5 per 100,000 person years.  These tumors can necessitate invasive surgery with serious health risks and potential complications.

The Link Between Depo-Provera and Meningiomas

Several studies have suggested a link between the synthetic progestin in Depo-Provera and the development of meningiomas. Long-term use of progestin-based medications, particularly at high doses, has been associated with an increased risk of developing these brain tumors.

A March 2024 study published in the British Medical Journal, utilizing data from the French National Health Data System, showed a 5.5 times increased risk of developing meningiomas in women who had used progestin-based medications like Depo-Provera. This substantial rise in risk has added urgency to the calls for greater transparency about the potential dangers of long-term use of hormonal therapies like Depo-Provera.

The study’s findings align with earlier research, reinforcing the concerns that women using Depo-Provera over extended periods may face a heightened risk of developing these tumors.

Depo-Provera Contraceptive Litigation

Many of the lawsuits filed against Pfizer allege that the company failed to properly warn patients and healthcare providers about the risk of developing meningiomas linked to long-term Depo-Provera use. Plaintiffs argue that if they had been fully informed about these risks, they might have chosen alternative forms of contraception or closely monitored their health for early signs of brain tumors.

Women affected by meningiomas may face significant medical challenges, including surgeries, radiation treatments, and ongoing monitoring. The lawsuits claim that Pfizer was negligent in its duty to inform consumers, resulting in unnecessary harm and suffering.

As of November 27, 2024, there were 22 cases filed in United States Federal Courts. If you developed a meningioma after using Depo-Provera, you may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more.

Get Legal Help

As more women come forward with their experiences, the Depo-Provera lawsuits continue to grow in number. For those affected, the potential for compensation could help cover medical bills, lost wages, and other damages associated with the diagnosis and treatment of meningiomas.

If you or a loved one has used Depo-Provera and been diagnosed with a meningioma or other brain tumor, it’s important to consult with a legal professional who specializes in pharmaceutical litigation. Understanding your rights and exploring potential legal actions may provide the opportunity for recovery and justice.

‍